Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Frovatriptan as a Transitional Therapy in Medication Overuse Headache

This study is currently recruiting participants. (see Contacts and Locations)
Verified August 2016 by University of Calgary
Alberta Health Services
Information provided by (Responsible Party):
Farnaz Amoozegar, University of Calgary Identifier:
First received: January 5, 2010
Last updated: August 16, 2016
Last verified: August 2016
No Study Results Posted on for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: September 2017
  Estimated Primary Completion Date: September 2017 (Final data collection date for primary outcome measure)